Syngen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019
May 08, 2019 at 03:09 pm EDT
Share
Syngen Biotech Co., Ltd. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was TWD 264.395 million compared to TWD 192.824 million a year ago. Operating income was TWD 41.233 million compared to TWD 14.575 million a year ago. Net income was TWD 33.662 million compared to TWD 14.883 million a year ago. Basic earnings per share was TWD 1.46 compared to TWD 0.64 a year ago.
Syngen Biotech Co Ltd is a Taiwan-based company mainly engaged in the manufacture and distribution of active pharmaceutical ingredients and health food products. The Companyâs products mainly consist of active pharmaceutical ingredients, health food raw materials, medical equipment, such as bone density analyzers, blood glucose analyzers and biochemical analyzers, as well as animal health products and others. The Company distributes its products mainly in Taiwan, Iran, South Korea and Egypt.
SYNGEN BIOTECH CO.,LTD. 
